Literature DB >> 4950287

Tryptophan and an MAOI (nialamide) in the treatment of depression. A double-blind study.

J L Ayuso Gutierrez, J J Aliño.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4950287     DOI： 10.1159/000468258

Source DB:  PubMed          Journal:  Int Pharmacopsychiatry        ISSN： 0020-8272


× No keyword cloud information.
  3 in total

1.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Authors:  R D Levitan; J H Shen; R Jindal; H S Driver; S H Kennedy; C M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 2.  Tryptophan antidepressant 'physiological sedative': fact or fancy?

Authors:  A J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

Review 3.  Use of tryptophan in combination with other antidepressant treatments: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.